pSivida (NASDAQ:PSDV) Moves On Laidlaw \u0026 Co. Initiation. How Much Are Shares Worth?

November 21, 2017 - By Winifred Garcia

 pSivida (NASDAQ:PSDV) Moves On Laidlaw \u0026 Co. Initiation. How Much Are Shares Worth?

Investors sentiment increased to 1.23 in 2017 Q2. Its up 0.23, from 1 in 2017Q1. It increased, as 4 investors sold pSivida Corp. shares while 9 reduced holdings. 7 funds opened positions while 9 raised stakes. 5.76 million shares or 26.29% less from 7.81 million shares in 2017Q1 were reported.

Finemark Bancorp has 0.01% invested in pSivida Corp. (NASDAQ:PSDV) for 71,800 shares. Matrix Asset Advisors New York invested in 0.01% or 26,500 shares. Paragon Cap Management Ltd has invested 0.02% in pSivida Corp. (NASDAQ:PSDV). Tower Research Cap Ltd Company (Trc) owns 100 shares. Jpmorgan Chase And Co holds 0% or 21,839 shares in its portfolio. B T Capital Management Dba Alpha Capital Management reported 0.02% of its portfolio in pSivida Corp. (NASDAQ:PSDV). Jacobs Levy Equity has invested 0.01% of its portfolio in pSivida Corp. (NASDAQ:PSDV). Royal Bancshares Of Canada owns 505 shares or 0% of their US portfolio. California Employees Retirement reported 64,900 shares. Capital Advisers Ltd holds 0% or 10,000 shares. Creative Planning accumulated 35,000 shares. Pnc Fincl Services Group Inc holds 0% or 25,800 shares. Blackrock holds 124,330 shares. Art Ltd Liability Com owns 0% invested in pSivida Corp. (NASDAQ:PSDV) for 24,226 shares. Citadel Advisors Ltd Company stated it has 28,397 shares.

Since June 14, 2017, it had 1 buy, and 0 insider sales for $99,962 activity.

Why Has Laidlaw \u0026 Co. Given pSivida (NASDAQ:PSDV) a $5 Price Target

Research professionals at Laidlaw \u0026 Co. began coverage on pSivida (NASDAQ:PSDV) with a key Buy rating. The PT for PSDV is $5. It gives a possible upside of 287.60 % from firm’s last stock price.

Investors sentiment increased to 1.23 in 2017 Q2. Its up 0.23, from 1 in 2017Q1. It increased, as 4 investors sold pSivida Corp. shares while 9 reduced holdings. 7 funds opened positions while 9 raised stakes. 5.76 million shares or 26.29% less from 7.81 million shares in 2017Q1 were reported.

Finemark Bancorp has 0.01% invested in pSivida Corp. (NASDAQ:PSDV) for 71,800 shares. Matrix Asset Advisors New York invested in 0.01% or 26,500 shares. Paragon Cap Management Ltd has invested 0.02% in pSivida Corp. (NASDAQ:PSDV). Tower Research Cap Ltd Company (Trc) owns 100 shares. Jpmorgan Chase And Co holds 0% or 21,839 shares in its portfolio. B T Capital Management Dba Alpha Capital Management reported 0.02% of its portfolio in pSivida Corp. (NASDAQ:PSDV). Jacobs Levy Equity has invested 0.01% of its portfolio in pSivida Corp. (NASDAQ:PSDV). Royal Bancshares Of Canada owns 505 shares or 0% of their US portfolio. California Employees Retirement reported 64,900 shares. Capital Advisers Ltd holds 0% or 10,000 shares. Creative Planning accumulated 35,000 shares. Pnc Fincl Services Group Inc holds 0% or 25,800 shares. Blackrock holds 124,330 shares. Art Ltd Liability Com owns 0% invested in pSivida Corp. (NASDAQ:PSDV) for 24,226 shares. Citadel Advisors Ltd Company stated it has 28,397 shares.

Since June 14, 2017, it had 1 buy, and 0 insider sales for $99,962 activity.

pSivida Corp. (NASDAQ:PSDV) Ratings Coverage

Among 6 analysts covering pSivida (NASDAQ:PSDV), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. pSivida has $12.5000 highest and $5.0 lowest target. $7.75’s average target is 500.78% above currents $1.29 stock price. pSivida had 14 analyst reports since October 15, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, September 27 by H.C. Wainwright. On Tuesday, July 11 the stock rating was maintained by H.C. Wainwright with “Buy”. FBR Capital maintained the stock with “Buy” rating in Tuesday, June 13 report. The rating was maintained by H.C. Wainwright on Wednesday, November 8 with “Buy”. The company was maintained on Tuesday, June 13 by Ladenburg. The stock has “Buy” rating by Northland Capital on Wednesday, June 14. On Thursday, October 15 the stock rating was initiated by FBR Capital with “Outperform”. The firm has “Buy” rating by H.C. Wainwright given on Wednesday, June 14. The stock of pSivida Corp. (NASDAQ:PSDV) earned “Buy” rating by H.C. Wainwright on Wednesday, October 11. The stock of pSivida Corp. (NASDAQ:PSDV) has “Buy” rating given on Tuesday, September 12 by H.C. Wainwright.

About 72,327 shares traded. pSivida Corp. (NASDAQ:PSDV) has declined 20.28% since November 21, 2016 and is downtrending. It has underperformed by 36.98% the S&P500.

Analysts await pSivida Corp. (NASDAQ:PSDV) to report earnings on February, 6. After $-0.15 actual earnings per share reported by pSivida Corp. for the previous quarter, Wall Street now forecasts 6.67 % negative EPS growth.

pSivida Corp. develops drug delivery products primarily for the treatment of chronic eye diseases. The company has market cap of $58.37 million. The Firm operates through the biotechnology sector segment. It currently has negative earnings. The Firm has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase III clinical trials; ILUVIEN for diabetic macular edema , its lead licensed product that is sold in the United States and European Union (EU) countries, and Retisert.

More notable recent pSivida Corp. (NASDAQ:PSDV) news were published by: Globenewswire.com which released: “pSivida Corp. to Report Fourth Quarter and Fiscal Year 2017 Financial Results …” on September 05, 2017, also Globenewswire.com with their article: “pSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating …” published on November 07, 2017, Seekingalpha.com published: “pSivida: The Small Biotech With Big News Coming” on October 23, 2017. More interesting news about pSivida Corp. (NASDAQ:PSDV) were released by: Streetinsider.com and their article: “Laidlaw Starts pSivida Corp. (PSDV) at Buy” published on November 08, 2017 as well as Globenewswire.com‘s news article titled: “pSivida Corp. Achieves Significant Milestones Throughout FY 2017; Reports …” with publication date: September 11, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.